Doctors to remove Vietnamese man's 90kg tumour

A man left unable to walk by a tumour on his right leg that weighs more than the rest of his body went under the knife in Vietnam on Thursday to have the growth removed, hospital officials said.

Nguyen Duy Hai's massive 90 kilogramme (198 pounds) is to be cut away by a team of in a risky ten hour procedure that has only a 50 percent success rate, the France-Vietnam (FV) hospital in Ho Chi Minh City said.

Hai, 31, who suffers from a , has been living with the tumour since he was four years old, FV hospital's statement read.

He had part of his leg amputated when he was 17, but the tumour, which is not cancerous, continued to expand, making it difficult for Hai to walk and sleep.

The growth is thought to be the largest ever recorded in , according to state media, who have followed Hai's condition for years.

"This is a huge procedure with many risks, including the risk of death during surgery or post-operative care," the hospital said, adding that the patient and the family decided to proceed with the removal nonetheless.

The marathon operation is being led by American doctor McKay McKinnon, who successfully removed a tumour weighing 80 kilogrammes from a Romanian woman in 2004.

McKinnon has waived his fee for Hai's surgery and the remaining costs, estimated to come to 250 million dong (around $12,000), will be covered by donations, FV said.

Related Stories

Vietnam restricts online games after murder cases

date Jul 29, 2010

(AP) -- Vietnam has banned the advertisement of online games and restricted access after several cases in which young people committed murder or robbery to get money to pay to play, an official said Thursday.

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

date 15 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

date Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.